Lundbeck
HLUN-B.CO
#2582
Rank
NZ$9.50 B
Marketcap
$9.97
Share price
-0.98%
Change (1 day)
32.14%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): NZ$0.75 Billion

According to Lundbeck 's latest financial reports the company's current earnings are NZ$3.14 Billion. In 2023 the company made an earning of NZ$0.78 Billion, an increase over its 2022 earnings that were of NZ$0.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.75 B-2.94%
2023 NZ$0.78 B21.69%
2022 NZ$0.64 B31.79%
2021 NZ$0.48 B-4.53%
2020 NZ$0.51 B-45.08%
2019 NZ$0.92 B-33.97%
2018 NZ$1.40 B12.76%
2017 NZ$1.24 B94.32%
2016 NZ$0.64 B-136.98%
2015 -NZ$1.74 Billion-1258.1%
2014 NZ$0.14 B-72.43%
2013 NZ$0.54 B4.31%
2012 NZ$0.52 B-55.26%
2011 NZ$1.16 B6.64%
2010 NZ$1.09 B-6.68%
2009 NZ$1.17 B